Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDAC

This article was originally published in The Tan Sheet

Executive Summary

Last scheduled 1999 meeting, Dec. 2-3, has been canceled due to lack of agenda items. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7-8. NDAC last met on July 20 with the Arthritis Advisory Committee to consider the Rx-to-OTC switch of Merck's Flexeril 5 mg (1"The Tan Sheet" July 26, pp. 3-9)

You may also be interested in...



NDAC

Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)

NDAC

Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)

NDAC

Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)

Related Content

Topics

UsernamePublicRestriction

Register

PS090474

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel